TASK-3 channel deletion in mice recapitulates low-renin essential hypertension

Hypertension

Volumn 59, Issue 5, 2012, Pages 999-1005

  Guagliardo, Nick A ^a   Yao, Junlan ^a,b   Hu, Changlong ^a,b   Schertz, Elaine M ^a   Tyson, David A ^a   Carey, Robert M ^a   Bayliss, Douglas A ^a   Barrett, Paula Q ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b FUDAN UNIVERSITY   (China)

Author keywords

Aldosterone; Hyperaldosteronism; Low renin essential hypertension; TASK channels

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; CANDESARTAN; CREATININE; POTASSIUM CHANNEL; TWIK RELATED ACID SENSITIVE POTASSIUM CHANNEL 1; TWIK RELATED ACID SENSITIVE POTASSIUM CHANNEL 3; UNCLASSIFIED DRUG;

ALDOSTERONE URINE LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; HORMONE SYNTHESIS; LOW RENIN ESSENTIAL HYPERTENSION; MALE; MEMBRANE POTENTIAL; MOUSE; NONHUMAN; OSMOTIC MINIPUMP; PLASMA RENIN ACTIVITY; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; SALT LOADING; SODIUM INTAKE; SODIUM RESTRICTION; SYSTOLIC BLOOD PRESSURE;

ALDOSTERONE; ANGIOTENSIN II; ANIMALS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; POTASSIUM CHANNELS; RANDOM ALLOCATION; REAL-TIME POLYMERASE CHAIN REACTION; RENIN-ANGIOTENSIN SYSTEM; SENSITIVITY AND SPECIFICITY; SEQUENCE DELETION; SODIUM;

EID: 84860223991     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.189662     Document Type: Article

References (33)

1. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young WF Jr, Montori VM. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2008;93:3266-3281.
2. Gordon RD, Laragh JH, Funder JW. Low renin hypertensive states: perspectives, unsolved problems, future research. Trends Endocrinol Metab. 2005;16:108-113. (Pubitemid 40432460)
3. Mulatero P, Verhovez A, Morello F, Veglio F. Diagnosis and treatment of low-renin hypertension. Clin Endocrinol (Oxf). 2007;67:324-334. (Pubitemid 47283836)
4. Stowasser M, Gordon RD. The aldosterone-renin ratio and primary aldosteronism. Mayo Clin Proc. 2002;77:202-203.
5. Tomaschitz A, Maerz W, Pilz S, Ritz E, Scharnagl H, Renner W, Boehm BO, Fahrleitner-Pammer A, Weihrauch G, Dobnig H. Aldosterone/renin ratio determines peripheral and central blood pressure values over a broad range. J Am Coll Cardiol. 2010;55:2171-2180.
6. Padfield PL, Brown JJ, Lever AF, Schalekamp MA, Beevers DG, Davies DL, Robertson JI, Tree M. Is low-renin hypertension a stage in the development of essential hypertension or a diagnostic entity? Lancet. 1975;1: 548-550.
7. Kater CE, Biglieri EG. The syndromes of low-renin hypertension: "separating the wheat from the chaff." Arq Bras Endocrinol Metabol. 2004; 48:674-681.
8. Lim PO, Struthers AD, MacDonald TM. The neurohormonal natural history of essential hypertension: towards primary or tertiary aldosteronism? J Hypertens. 2002;20:11-15. (Pubitemid 34913396)
9. Vasan RS, Evans JC, Larson MG, Wilson PW, Meigs JB, Rifai N, Benjamin EJ, Levy D. Serum aldosterone and the incidence of hypertension in nonhypertensive persons. N Engl J Med. 2004;351:33-41.
10. Meneton P, Galan P, Bertrais S, Heudes D, Hercberg S, Menard J. High plasma aldosterone and low renin predict blood pressure increase and hypertension in middle-aged Caucasian populations. J Hum Hypertens. 2008;22:550-558.
11. Choi M, Scholl UI, Yue P, Bjorklund P, Zhao B, Nelson-Williams C, Ji W, Cho Y, Patel A, Men CJ, Lolis E, Wisgerhof MV, Geller DS, Mane S, Hellman P, Westin G, Akerstrom G, Wang W, Carling T, Lifton RP. Kchannel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science. 2011;331:768-772.
12. Lotshaw DP. Role of membrane depolarization and t-type ca2αchannels in angiotensin II and Kstimulated aldosterone secretion. Mol Cell Endocrinol. 2001;175:157-171. (Pubitemid 32372552)
13. Quinn SJ, Cornwall MC, Williams GH. Electrical properties of isolated rat adrenal glomerulosa and fasciculata cells. Endocrinology. 1987;120: 903-914. (Pubitemid 17016730)
14. Arrighi I, Bloch-Faure M, Grahammer F, Bleich M, Warth R, Mengual R, Drici MD, Barhanin J, Meneton P. Altered potassium balance and aldosterone secretion in a mouse model of human congenital long qt syndrome. Proc Natl Acad Sci USA. 2001;98:8792-8797. (Pubitemid 32678106)
15. Davies LA, Hu C, Guagliardo NA, Sen N, Chen X, Talley EM, Carey RM, Bayliss DA, Barrett PQ. Task channel deletion in mice causes primary hyperaldosteronism. Proc Natl Acad Sci USA. 2008;105:2203-2208. (Pubitemid 351439489)
16. Heitzmann D, Derand R, Jungbauer S, Bandulik S, Sterner C, Schweda F, El Wakil A, Lalli E, Guy N, Mengual R, Reichold M, Tegtmeier I, Bendahhou S, Gomez-Sanchez CE, Aller MI, Wisden W, Weber A, Lesage F, Warth R, Barhanin J. Invalidation of TASK1 potassium channels disrupts adrenal gland zonation and mineralocorticoid homeostasis. EMBO J. 2008;27:179-187.
17. Czirjak G, Enyedi P. TASK-3 dominates the background potassium conductance in rat adrenal glomerulosa cells. Mol Endocrinol. 2002;16:621-629. (Pubitemid 34214580)
18. Czirjak G, Enyedi P. Formation of functional heterodimers between the TASK-1 and TASK-3 two-pore domain potassium channel subunits. J Biol Chem. 2002;277:5426-5432. (Pubitemid 34968590)
19. Lotshaw DP. Effects of Kchannel blockers on Kchannels, membrane potential, and aldosterone secretion in rat adrenal zona glomerulosa cells. Endocrinology. 1997;138:4167-4175. (Pubitemid 27408457)
20. Collins RD, Weinberger MH, Dowdy AJ, Nokes GW, Gonzales CM, Luetscher JA. Abnormally sustained aldosterone secretion during salt loading in patients with various forms of benign hypertension; relation to plasma renin activity. J Clin Invest. 1970;49:1415-1426.
21. Marks AD, Marks DB, Kanefsky TM, Adlin VE, Channick BJ. Enhanced adrenal responsiveness to angiotensin II in patients with low renin essential hypertension. J Clin Endocrinol Metab. 1979;48:266-270. (Pubitemid 9122239)
22. Wisgerhof M, Brown RD. Increased adrenal sensitivity to angiotensin II in low-renin essential hypertension. J Clin Invest. 1978;61:1456-1462. (Pubitemid 8361871)
23. Griffing GT, Wilson TE, Melby JC. Alterations in aldosterone secretion and metabolism in low renin hypertension. J Clin Endocrinol Metab. 1990;71:1454-1460. (Pubitemid 120032759)
24. Lazarenko RM, Willcox SC, Shu S, Berg AP, Jevtovic-Todorovic V, Talley EM, Chen X, Bayliss DA. Motoneuronal task channels contribute to immobilizing effects of inhalational general anesthetics. J Neurosci. 2010;30:7691-7704.
25. Guagliardo NA, Yao J, Bayliss DA, Barrett PQ. Task channels are not required to mount an aldosterone secretory response to metabolic acidosis in mice. Mol Cell Endocrinol. 2011;336:47-52.
26. Dluhy RG, Axelrod L, Underwood RH, Williams GH. Studies of the control of plasma aldosterone concentration in normal man: II-effect of dietary potassium and acute potassium infusion. J Clin Invest. 1972;51: 1950-1957.
27. Pratt JH. Role of angiotensin II in potassium-mediated stimulation of aldosterone secretion in the dog. J Clin Invest. 1982;70:667-672. (Pubitemid 12054593)
28. Wotus C, Levay-Young BK, Rogers LM, Gomez-Sanchez CE, Engeland WC. Development of adrenal zonation in fetal rats defined by expression of aldosterone synthase and 11γ-hydroxylase. Endocrinology. 1998;139: 4397-4403. (Pubitemid 28513730)
29. Boulkroun S, Samson-Couterie B, Dzib JF, Lefebvre H, Louiset E, Amar L, Plouin PF, Lalli E, Jeunemaitre X, Benecke A, Meatchi T, Zennaro MC. Adrenal cortex remodeling and functional zona glomerulosa hyperplasia in primary aldosteronism. Hypertension. 2010;56:885-892.
30. Makhanova N, Hagaman J, Kim HS, Smithies O. Salt-sensitive blood pressure in mice with increased expression of aldosterone synthase. Hypertension. 2008;51:134-140. (Pubitemid 350307115)
31. Aguilar F, Lo M, Claustrat B, Saez JM, Sassard J, Li JY. Hypersensitivity of the adrenal cortex to trophic and secretory effects of angiotensin II in Lyon genetically-hypertensive rats. Hypertension. 2004;43:87-93. (Pubitemid 38031915)
32. Aguilera G, Catt KJ. Participation of voltage-dependent calcium channels in the regulation of adrenal glomerulosa function by angiotensin II and potassium. Endocrinology. 1986;118:112-118. (Pubitemid 16186421)
33. Barrett PQ, Bollag WB, Isales CM, McCarthy RT, Rasmussen H. Role of calcium in angiotensin II-mediated aldosterone secretion. Endocr Rev. 1989;10:496-518. (Pubitemid 20001021)